BSX
Boston Scientific·NYSE
--
--(--)
--
--(--)
BSX fundamentals
Boston Scientific (BSX) Revenue Breakdown: Q3 2025 Business & Regional Performance
Boston Scientific (BSX) reported total revenue of 5.07B USD in Q3 2025, with its core business segment Medsurg contributing 34.00%. Regionally, United States remained the largest market, accounting for 65.05% of total revenue. Explore Boston Scientific's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Boston Scientific (BSX) reported total revenue of 5.07B USD in Q3 2025, with its core business segment Medsurg contributing 34.00%. Regionally, United States remained the largest market, accounting for 65.05% of total revenue. Explore Boston Scientific's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is Boston Scientific's gross profit margin?What factors drove the changes in Boston Scientific's revenue and profit?What does Boston Scientific do and what are its main business segments?What is the revenue and EPS growth rate for Boston Scientific year over year?What is Boston Scientific's latest dividend and current dividend yield?What were the key takeaways from Boston Scientific's earnings call?What guidance did Boston Scientific's management provide for the next earnings period?Did Boston Scientific beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
